- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 70.49M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.25B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $2.77B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.55B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.55B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $1.31B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $1.39B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $3.45B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $3.12B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $8.24B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $8.71B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $9.08B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $8.68B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $18.55B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $17.96B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 73.55M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $288.83M |
| Capex | Q1 2025 · Mar 31, 2024 | $41.19M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $350.18M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $3.12 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $3.20 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $151.26M |
| Net Income | Q1 2025 · Mar 31, 2024 | $229.77M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $397.34M |